SCHEMBL3655265

SCHEMBL3655265

COc1cc(C(=O)NCCC(N)=O)cc(N(C2CN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)C2)S(C)(=O)=O)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
F2 P00734 2/20 0.37
DDR1 Q08345 1/20 0.37
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
DRD2 P14416 4/20 0.35
DRD4 P21917 4/20 0.35
MAPT P10636 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
PMP22 Q01453 1/20 0.35
DRD3 P35462 1/20 0.35
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
CACNA1G O43497 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3656172 0.90 F2 (0.46) KMT2AF2LMNADRD2DRD3
SCHEMBL3659731 0.89 F2 (0.38) KMT2AF2DDR1DRD2DRD3
SCHEMBL3655106 0.89 F2 (0.38) KMT2AF2DDR1DRD2DRD3
SCHEMBL977615 0.87 ALOX5 (0.39) MEN1KMT2AF2LMNAL3MBTL1
SCHEMBL976313 0.85 HPGDS (0.37) MEN1KMT2AF2DDR1LMNA
SCHEMBL977990 0.85 F2 (0.37) MEN1KMT2AF2DDR1DRD2
SCHEMBL3660860 0.85 F2 (0.37) KMT2AF2DDR1DRD2MAPT
SCHEMBL977235 0.85 SLC6A9 (0.36) KMT2AF2LMNACACNA1G
SCHEMBL3664045 0.84 F2 (0.36) KMT2AF2DRD2DRD3CACNA1G
SCHEMBL3404166 0.84 MEN1 (0.38) MEN1KMT2AF2DDR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234966-A2 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY Sanofi-Aventis (FR) 2010-10-06 EP claimed
WO-2009106708-A2 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI-AVENTIS (FR) 2009-09-03 WO claimed